Exactech Announces First Total Ankle Surgeries in South America

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced first surgeries in Latin America with the Vantage® Total Ankle Fixed Bearing System.

Manuel Pellegrini, MD, and Giovanni Carcuro, MD, of the Clinica Universidad de los Andes, performed the bilateral ankle procedures in Chile earlier this month.

“Many patients worldwide are benefitting from the Vantage Ankle, and I’m honored to be the first to use it on my continent,” said Dr. Pellegrini. “My patient not only received one, but two Exactech implants, and I look forward to seeing their progress post-surgery.”

The Vantage Ankle was first launched in the U.S. in 2016 and received clearance in Chile earlier this year. It is designed to recreate the natural biomechanics of the ankle joint through its curved talus component, which aligns with the talus’ trabecular bone structure, and tibial implant. Specifically, the press-fit tibial component is designed for anatomic cortical coverage and fibular articulation and features a center bone cage and three plasma pegs that are engineered to create initial fixation.1 In addition, the system features a polyethylene liner and a unique locking clip for secure fastening of the polyethylene liner.

“We are thrilled to be part of this landmark procedure,” said Foot and Ankle Marketing Director Devan Carter. “The Vantage Ankle has helped many patients get back to what they love doing, and we’re happy to share these clinical results with patients and surgeons in Chile. We hope to expand into other Latin American countries in the future.”

SourceExactech
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version